D

Diffusion Pharmaceuticals Inc
NASDAQ:CRVO

Watchlist Manager
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Watchlist
Price: 7.41 USD -2.11% Market Closed
Market Cap: 64.5m USD

Wall Street
Price Targets

CRVO Price Targets Summary
Diffusion Pharmaceuticals Inc

Wall Street analysts forecast CRVO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRVO is 16.15 USD with a low forecast of 10.1 USD and a high forecast of 22.05 USD.

Lowest
Price Target
10.1 USD
36% Upside
Average
Price Target
16.15 USD
118% Upside
Highest
Price Target
22.05 USD
198% Upside
Diffusion Pharmaceuticals Inc Competitors:
Price Targets
ORKA
Oruka Therapeutics Inc
177% Upside
PRQR
ProQR Therapeutics NV
306% Upside
VNDA
Vanda Pharmaceuticals Inc
170% Upside
2616
CStone Pharmaceuticals
3% Downside
MDGL
Madrigal Pharmaceuticals Inc
29% Upside
DVYSR
Devyser Diagnostics AB
28% Upside
TNGX
Tango Therapeutics Inc
51% Upside
6160
Beigene Ltd
16% Upside

Revenue
Forecast

Revenue Estimate
Diffusion Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Diffusion Pharmaceuticals Inc's revenue is 24%.

24%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Diffusion Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Diffusion Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRVO's stock price target?
Price Target
16.15 USD

According to Wall Street analysts, the average 1-year price target for CRVO is 16.15 USD with a low forecast of 10.1 USD and a high forecast of 22.05 USD.

Back to Top